Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared on X:
”Amazing talk on ‘ADCs in GU cancers’ by the terrific Guru P. Sonpavde at the STOP cancer summit.
Such a delight to be at the –‘STOP cancer meeting’ – Summit for Novel therapies in Oncology and Precision Medicines in Cancer. Fantastic colleagues presenting today.”
Other articles about ADCs OncoDaily.
